HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters

Some studies do not list a clear city. Always confirm the location with the study team.

Some visits may still be in person. Participation depends on the study’s location and eligibility requirements.

4317studies shown
Showing 181-192 of 4,317
Behavioral study icon
RecruitingACTRN12608000400369

Directly observed peginterferon alfa-2a with ribavirin for Mental health

Official study title

A single-arm, open-label, pilot study evaluating the efficacy and safety of directly observed peginterferon alfa-2a with ribavirin in conjunction with a peer counsellor in patients actively using injecting drugs who have chronic hepatitis C and attend a drug and alcohol centre.

Location not clearly listed
Mental healthInterventional studyAges 18+
Countries
Sponsor
Dr Joe Sasadeusz
Behavioral study icon
RecruitingNCT06363266

Optimizing online TEMPO support for men with prostate cancer and caregivers

About this title

A SMART Design to Optimize the Delivery of TEMPO for Men With Prostate Cancer and Their Caregivers

Read the official source — NCT06363266
Official study title

A SMART Design to Optimize the Delivery of TEMPO - a Tailored, wEb-based Psychosocial and Physical Activity Self-Management PrOgram for Men With Prostate Cancer and Their Caregivers

Multiple locations, including Montreal
AnxietyBehavioural studyAges 18+
Countries
Canada
Sponsor
St. Mary's Research Center, Canada
Drug study icon
RecruitingACTRN12608000059369

Brain imaging in children with ADHD

What is this study about?

Researchers examine brain structure and activity, with MRI sessions after methylphenidate and placebo in the ADHD group.

In China
ADHDMRI + medicationAges 11–16
Countries
China
Sponsor
Children Psychiatry Department, Institute of Mental Health, Peking University
Behavioral study icon
RecruitingACTRN12625001199404

A study comparing a new group cognitive behavioural therapy (CBT) to standard dialectical behaviour therapy (DBT) in adults with binge Eating disorders

Official study title

A Quasi-Experimental Study comparing a novel group cognitive behavioural therapy intervention with standard group dialectical behaviour therapy for binge eating disorder in adults

In Greece
Eating disordersInterventional studyAges 18–70
Countries
Greece
Sponsor
Medical School - National and Kapodistrian University of Athens
Drug study icon
RecruitingNCT04375033

Comparing daily and long-acting buprenorphine for opioid use disorder

About this title

A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder

Read the official source — NCT04375033
Official study title

CSP #2014 - Comparative Effectiveness of Two Formulations of Buprenorphine for Treating Opioid Use Disorder in Veterans (VA-BRAVE)

Multiple locations, including Phoenix
AddictionMedication studyAges 18+
Countries
United States
Sponsor
VA Office of Research and Development (Government agency)
Other study type icon
RecruitingNCT06693700

Indoor air monitor to support smoke-free homes for people receiving cancer care

About this title

A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home

Read the official source — NCT06693700
Official study title

Freedom to Breathe: Pilot Study Towards Achieving Environmental Justice for Cancer Patients and Their Families

Multiple locations, including Basking Ridge
AddictionInterventional studyAges 18+
Countries
United States
Sponsor
Memorial Sloan Kettering Cancer Center
Drug study icon
RecruitingNCT07226895

A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis

Official study title

A Study to Explore Changes in Cognitive, Clinical, Biological and Digital Measures Following 8 Weeks of Twice-daily Dosing of MT1988 and to Evaluate Safety & Tolerability of MT1988, in Participants at Clinical High Risk (CHR) for Psychosis

Multiple locations, including Irvine
SchizophreniaMedication studyAges 17–30
Countries
United States
Sponsor
Monument Therapeutics Limited

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.